Deltasone

Pemphigus, Ophthalmia, Sympathetic, Chorioretinitis + 95 more
Treatment
55 FDA approvals
20 Active Studies for Deltasone

What is Deltasone

PrednisoneThe Generic name of this drug
Treatment SummaryPrednisone is a type of synthetic steroid used to reduce inflammation and swelling in the body. It is converted to prednisolone in the liver and was approved by the FDA in 1955.
PredniSONEis the brand name
image of different drug pills on a surface
Deltasone Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
PredniSONE
Prednisone
1972
681

Approved as Treatment by the FDA

Prednisone, commonly known as PredniSONE, is approved by the FDA for 55 uses which include Anemia, Hemolytic and Thrombocytopenia .
Anemia, Hemolytic
Thrombocytopenia
Conjunctivitis
Helps manage Ocular Inflammation
non-suppurative Thyroiditis
Primary adrenocortical insufficiency
Uremia
Mycosis Fungoides (MF)
Helps manage Mycosis Fungoides (MF)
Secondary thrombocytopenia
Adrenal Cortex Hormones
Helps manage unresponsive to topical corticosteroids
acquired immune hemolytic anemia
Diuresis
Crohn Disease
Helps manage acute Crohn's Disease (CD)
Atopic Dermatitis
Helps manage Atopic Dermatitis
Congenital Hypoplastic Anemia
Congenital Adrenal Hyperplasia (CAH)
Neurologic Involvement
Immune Thrombocytopenia (ITP)
Disseminated tuberculosis
Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid
Allergic Rhinitis (AR)
Helps manage Allergic Rhinitis (AR)
Drug hypersensitivity reaction
Contact Dermatitis
Mycosis Fungoides
Helps manage Mycosis Fungoides (MF)
Thyroiditis
Ulcerative Colitis
Helps manage Ulcerative Colitis
Sarcoidosis
Helps manage symptomatic Sarcoidosis
Secondary adrenocortical insufficiency
Malignant Neoplasms
Stevens-Johnson Syndrome
induction of Diuresis
Idiopathic Nephrotic Syndrome
symptomatic Sarcoidosis
Helps manage symptomatic Sarcoidosis
Asthma
Helps manage Asthma
Ulcerative Colitis
Helps manage Ulcerative Colitis
Ocular Inflammation
Helps manage Ocular Inflammation
Pemphigus
Helps manage Pemphigus
Trichinosis
Pemphigus
Helps manage Pemphigus
Systemic Lupus Erythematosus (SLE)
Adrenal Insufficiency
Addison Disease
Lupus Erythematosus
Proteinuria
Uremia
Bullous dermatitis herpetiformis
Helps manage Bullous dermatitis herpetiformis
Tuberculosis
Used to treat fulminating Tuberculosis in combination with Aminosalicylic acid
Serum Sickness
exfoliative erythroderma
Helps manage exfoliative erythroderma
Anemia, Diamond-Blackfan
Lupus
Congenital adrenal hyperplasia
Patient Participation
Tuberculosis
Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid
Aspiration Pneumonitis
Drug Allergy
Asthma
Helps manage Asthma

Effectiveness

How Deltasone Affects PatientsPrednisone is a type of medication that works by blocking certain signals in the body that cause inflammation. It only remains in the body for a few hours, and patients may need to take doses that are higher than what the body produces naturally. People taking this medication should be aware of the potential side effects, such as an increased risk of infections and suppression of the hypothalamic-pituitary-adrenal axis.
How Deltasone works in the bodyPrednisone is changed in the liver to its active form, prednisolone. This works to narrow blood vessels and reduce the flow of white blood cells to inflamed areas of the body. It also prevents cells from dying, lowers the formation of certain acids, and helps produce anti-inflammatory substances. Low doses of prednisolone reduce inflammation, while high doses weaken the immune system. When taken for a long time, prednisolone can raise sodium levels and lower potassium levels.

When to interrupt dosage

The measure of Deltasone is contingent upon the recognized affliction, including Malignant Lymphomas, Thyroiditis and Tuberculosis Meningitis. The magnitude of dosage is subject to the technique of delivery (e.g. Oral or Solution, concentrate) featured in the table beneath.
Condition
Dosage
Administration
Dermatomyositis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
prophylaxis of graves ophthalmopathy
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Craniotomy
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
exfoliative erythroderma
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Addison Disease
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
varicella-zoster virus acute retinal necrosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Psoriasis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Trichinosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
induction of Diuresis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Diuresis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Sarcoidosis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Brain
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Brain
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Optic Neuritis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Congenital adrenal hyperplasia
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Malignant Neoplasms
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
HIV Positive
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Red-Cell Aplasia, Pure
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Psoriatic Arthritis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit
Ulcerative Colitis
, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg
, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Solution, concentrate, Tablet, delayed release - Oral, Tablet, delayed release, Kit

Warnings

Deltasone Contraindications
Condition
Risk Level
Notes
Mycoses
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Prednisone may interact with Pulse Frequency
There are 20 known major drug interactions with Deltasone.
Common Deltasone Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Abatacept.
Abetimus
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Abetimus.
Acteoside
Major
The risk or severity of adverse effects can be increased when Prednisone is combined with Acteoside.
Deltasone Toxicity & Overdose RiskTaking too much prednisone can lead to a range of unpleasant side effects, such as mental symptoms, fullness in the face, fat deposits, fluid retention, increased appetite, weight gain, increased body hair, acne, stretch marks, bruising, excessive sweating, skin discoloration, thinning hair on the scalp, high blood pressure, rapid heartbeat, difficulty fighting infections, delayed healing of wounds and bones, headaches, weakness, irregular menstrual cycles, worsened menopausal symptoms, nerve damage, bone fractures, reduced bone density, stomach ulcers, decreased blood sugar levels, low potassium levels, and reduced adrenal gland function.
image of a doctor in a lab doing drug, clinical research

Deltasone Novel Uses: Which Conditions Have a Clinical Trial Featuring Deltasone?

70 active studies are currently evaluating the effectiveness of Deltasone for Adrenal Cortex Hormones, Disseminated Tuberculosis and Idiopathic Thrombocytopenic Purpura.
Condition
Clinical Trials
Trial Phases
Drug Allergy
2 Actively Recruiting
Phase 3, Phase 2
Asthma
92 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3
Tuberculosis
0 Actively Recruiting
Relapsing Polychondritis
1 Actively Recruiting
Phase 2
Giant Cell Arteritis
3 Actively Recruiting
Phase 3, Phase 1, Phase 2
Lupus
65 Actively Recruiting
Phase 2, Not Applicable, Phase 1, Phase 3, Phase 4, Early Phase 1
Tennis Elbow
0 Actively Recruiting
Acute Coryza
0 Actively Recruiting
Ulcerative Colitis
14 Actively Recruiting
Phase 3, Phase 2, Not Applicable, Phase 4, Phase 1
Bell Palsy
0 Actively Recruiting
Polymyalgia Rheumatica
3 Actively Recruiting
Phase 3, Phase 2
Patient Participation
0 Actively Recruiting
Crohn Disease
0 Actively Recruiting
Chorioretinitis
0 Actively Recruiting
Acne Vulgaris
2 Actively Recruiting
Phase 1, Phase 2, Early Phase 1
Brain
7 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1
acute Bursitis
0 Actively Recruiting
Brain
0 Actively Recruiting
Arthritis, Juvenile
1 Actively Recruiting
Not Applicable
Bullous dermatitis herpetiformis
0 Actively Recruiting

Deltasone Reviews: What are patients saying about Deltasone?

5Patient Review
7/15/2010
Deltasone for Psoriasis associated with Arthritis
I was pleased to find that, after reading some negative reviews, short-term use of this medication seems to be just fine. My son has had to take it twice now and I'm always a bit hesitant when it comes to giving him medicine. He hates the initial taste and the even worse aftertaste, but thankfully it doesn't last too long.
5Patient Review
12/31/2010
Deltasone for Crohn's Disease
I've only been using this treatment for nine days, but it has already done wonders for my psoriasis and arthritis. My hands are almost clear of the rash, and my joints feel better than they have in a long time. I hope I can keep taking this medication!
5Patient Review
3/12/2021
Deltasone for Joint Disease which may include Attacks of Acute Arthritis
This is the only treatment for gouty arthritis that actually works, in my opinion.
4.7Patient Review
7/1/2013
Deltasone for Myasthenia Gravis
I've been using this medication for years, and it has definitely improved my quality of life. The side effects are a bit of a nuisance, but overall I'm happy with the results.
4.7Patient Review
9/18/2009
Deltasone for Asthma
4Patient Review
1/17/2013
Deltasone for Allergic Reaction caused by a Drug
I've found that this treatment helps with my sleeping problems and anxiety, as well as my acne. It's not a perfect solution, but it's much better than what I was dealing with before.
3.7Patient Review
12/26/2013
Deltasone for Rheumatoid Arthritis
While this medication does help me to breathe, I am always feeling really sick now and my stomach is constantly under pressure. I think this medicine is the cause, but I can't breath without it.
3.3Patient Review
9/23/2013
Deltasone for Inflammation & Obstruction of Smallest Breathing Passages
I was lucky and experienced few negative side effects. This drug successfully treated my condition.
2Patient Review
10/16/2013
Deltasone for Inflammation & Obstruction of Smallest Breathing Passages
This medication gave me a skin rash and intense itchiness.
1.3Patient Review
9/9/2009
Deltasone for Crohn's Disease
1Patient Review
7/24/2009
Deltasone for Asthma

Patient Q&A Section about deltasone

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Deltasone a steroid?

"Deltasone suppresses cells in the human immune system, which helps to treat a large number of health problems."

Answered by AI

What is the difference between prednisone and Deltasone?

"Deltasone, Liquid Pred, Meticorten, and Orasone are all trade names for the generic drug Prednisone. In some cases, health care professionals may use one of these trade names when referring to Prednisone."

Answered by AI

What are the side effects of the medication Deltasone?

"These are some of the side effects that may occur when taking this medication. If any of these effects persist or worsen, inform your doctor or pharmacist immediately."

Answered by AI

What does Deltasone used for?

"Deltasone is a prescription medication used to relieve the symptoms of various conditions such as arthritis, blood disorders, breathing difficulties, severe allergies, skin diseases, cancer, eye problems and disorders of the immune system. It can be used on its own or in conjunction with other medications."

Answered by AI

Clinical Trials for Deltasone

Image of California Clinical Trials Medical Group in Glendale, United States.

NTR-1011 for Lupus and Rheumatoid Arthritis

18 - 75
All Sexes
Glendale, CA
This phase 1a and 1b study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of NTR-1011 in healthy adults and in adult patients with systemic lupus erythematosus and rheumatoid arthritis. The main goals of this study are to determine the safety profile of NTR-1011 across subcutaneous and intravenous dose levels, understand how the drug behaves in the body, characterize its biological activity through relevant pharmacodynamic markers, assess the potential for immune responses to treatment, and explore early signals of clinical benefit in autoimmune disease settings. This is a randomized, double blind, placebo controlled study that begins with a single ascending dose evaluation in healthy volunteers followed by a multiple dose assessment in patients. The design is intended to define the highest safe and well tolerated dose, establish a robust PK and PD baseline, and generate initial patient level evidence to support dose selection and advancement into subsequent clinical development.
Phase 1
Recruiting
California Clinical Trials Medical GroupHakop Gevorkyan, MDNeutrolis
Have you considered Deltasone clinical trials? We made a collection of clinical trials featuring Deltasone, we think they might fit your search criteria.Go to Trials
Image of Humana Healthcare Research, Inc. in Louisville, United States.

Academic Detailing for Rheumatoid Arthritis

Any Age
All Sexes
Louisville, KY
The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions for biosimilar versions of adalimumab? 2. Do in-person or virtual visits work better? Researchers will compare clinicians offered the educational outreach visit to those who are not offered the visit to see if there is a difference in prescribing of biosimilar versions of adalimumab instead of the original brand-name version. Participants will be offered the chance to meet with a trained clinician who will provide educational information tailored to their knowledge and attitudes on the topic. They will also be provided an educational brochure and patient educational materials.
Waitlist Available
Has No Placebo
Humana Healthcare Research, Inc. (+1 Sites)
Image of Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016) in New York, United States.

Electromagnetic Resonance Therapy for Autoimmune Diseases

Any Age
All Sexes
New York, NY
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with each other. The goal is to see if this "quantum-synaptic" signaling effect can help stabilize immune activity and reduce the number of autoimmune flare-ups in people living with conditions such as lupus, rheumatoid arthritis, or multiple sclerosis. Participants will receive either an active or a sham (placebo) LF-EMR session three times per week for twelve weeks. Each session is completely non-invasive. Blood samples will be collected to study cytokines (immune-system messenger molecules), gene-expression patterns, and electrical field coherence among immune cells. A machine-learning system will analyze these data to predict inflammation patterns and guide individualized treatment settings. All participant data will be securely recorded and time-stamped to ensure transparency and privacy. The expected outcome of the study is a measurable reduction in autoimmune flare frequency and symptom severity, along with improved understanding of how electromagnetic signaling might safely regulate immune function.
Phase 1 & 2
Waitlist Available
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)Gavin Solomon, President & CEOTruway Health, Inc.
Have you considered Deltasone clinical trials? We made a collection of clinical trials featuring Deltasone, we think they might fit your search criteria.Go to Trials
Image of BAMF Health in Grand Rapids, United States.

AB001 for Prostate Cancer

18+
Male
Grand Rapids, MI
This study is designed to investigate the safety, tolerability, and effectiveness of a new treatment called AB001 in both 177Lu-PSMA naïve and 177Lu-PSMA experienced patients with advanced prostate cancer. AB001 targets a specific protein found on prostate cancer cells called prostate specific membrane antigen (PSMA) and delivers radioactive particles to kill the cancer cells. The primary goal of the study is to determine the safety profile of AB001 and how well patients tolerate the treatment. Researchers also aim to identify the best dose and schedule for further testing and clinical development. AB001 could be a promising treatment because it uses alpha particles, which are highly effective at damaging cancer cells while causing minimal harm to surrounding healthy tissue. This targeted approach is expected to result in fewer side effects compared to other types of radiation therapy. This Phase 1 study consists of two main parts: dose escalation and dose expansion. In the first part, researchers will test different doses of AB001 to find the safest and most effective dose. In the second part, the selected dose will be further evaluated to refine the treatment schedule and gather more data on its effectiveness and safety. The study aims to provide early data on the anti-tumour activity of AB001 and determine the best dose and treatment schedule for future trials. Researchers hope that AB001 will offer a new and effective treatment option for patients with advanced prostate cancer.
Phase 1
Recruiting
BAMF Health (+3 Sites)Margaret YuARTBIO Inc.
Have you considered Deltasone clinical trials? We made a collection of clinical trials featuring Deltasone, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security